[1] BONJOUR J P, CHEVALLEY T, FARDELLONE P.Calcium intake and vitamin D metabolism and action, in healthy conditions and in prostate cancer[J].The British Journal of Nutrition, 2007, 97(4):611-616.

[2] BIKLE D.Nonclassic actions of vitamin D[J].The Journal of Clinical Endocrinology and Metabolism, 2009, 94(1):26-34.
[3] 李思明, 欧阳玲花, 韦启鹏, 等.维生素D
3的免疫功能及其对家禽免疫细胞和免疫因子的调节[J].动物营养学报, 2012, 24(7):1189-1192.
[4] 李思明, 周定刚.维生素D
3对丝毛乌鸡的3个β-防御素基因在不同组织中表达的影响[J].营养学报, 2010, 22(1):93-94, 96.
[5] JONES G.Phosphorus metabolism and management in chronic kidney disease:expanding role for vitamin D in chronic kidney disease:importance of blood 25-OH-D levels and extra-renal 1α-hydroxylase in the classical and nonclassical actions of 1α, 25-dihydroxyvitamin D
3[J].Seminars in Dialysis, 2007, 20(4):316-324.

[6] 李思明, 周定刚.维生素D
3对丝毛乌骨鸡组织中β-防御素基因的表达调控[J].动物营养学报, 2009, 21(4):573-579.
[7] LI S M, OUYANG L H, ZHOU D G.Effects of vitamin D
3 on expression of defensins, Toll-like receptors, and vitamin D receptor in liver, kidney, and spleen of Silky fowl[J].Czech Journal of Animal Science, 58(1):1-7.
[8] O'KELLY J, HISATAKE J, HISATAKE Y, et al.Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice[J].The Journal of Clinical Investigation, 2002, 109(8):1091-1099.
[9] FROICU M, CANTORNA M T.Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury[J].BMC Immunology, 2007, 8:5.
[10] KONG J, GRANDO S A, LI Y C.Regulation of IL-1 family cytokines IL-1alpha, IL-1 receptor antagonist, and IL-18 by 1, 25-dihydroxyvitamin D
3 in primary keratinocytes[J].Journal of Immunology, 2006, 176(6):3780-3787.
[11] TSE A K W, WAN C K, SHEN X L, et al.1, 25-dihydroxyvitamin D
3 induces biphasic NF-κB responses during HL-60 leukemia cells differentiation through protein induction and PI3K/Akt-dependent phosphorylation/degradation of IκB[J].Experimental Cell Research, 2007, 313(8):1722-1734.

[12] JAMES S Y, WILLIAMS M A, NEWLAND A C, et al.Leukemia cell differentiation:cellular and molecular interactions of retinoids and vitamin D[J].General Pharmacology:The Vascular System, 1999, 32(1):143-154.

[13] SZELES L, KERESZTES G, TOROCSIK D, et al.1, 25-dihydroxyvitamin D
3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype[J].Journal of Immunology, 2009, 182(4):2074-2083.

[14] GRIFFIN M D, DONG X Y, KUMAR R.Vitamin D receptor-mediated suppression of RelB in antigen presenting cells:a paradigm for ligand-augmented negative transcriptional regulation[J].Archives of Biochemistry and Biophysics, 2007, 460(2):218-226.

[15] MATHIEU C, VAN ETTEN E, DECALLONNE B, et al.Vitamin D and 1, 25-dihydroxyvitamin D
3 as modulators in the immune system[J].The Journal of Steroid Biochemistry and Molecular Biology, 2004, 89/90(1/2/3/4/5):449-452.